Target intelligence / Profile preview

Tetratricopeptide repeat domain 34 (TTC34)

Target
TTC34
Molecular classification
Other, Tetratricopeptide repeat domain-containing protein
01

Overview

Tetratricopeptide repeat domain 34 (TTC34) is a protein encoded by the TTC34 gene in humans and is a member of the tetratricopeptide repeat domain-containing protein family[3][6]. These proteins are characterized by the presence of multiple tetratricopeptide repeat (TPR) motifs, each consisting of a degenerate 34-amino acid sequence. TPR motifs facilitate protein–protein interactions by forming alpha-helical scaffolds that usually mediate the assembly of multiprotein complexes[1][5]. TTC34’s precise physiological functions remain uncharacterized, and there is little experimental data confirming a distinct role in human biology or disease. Based on gene expression studies, it appears to be broadly expressed in various tissues, but there is no evidence to support its specific involvement as a drug target, biomarker, or significant disease gene. Most knowledge about TTC34 is based on bioinformatic prediction of domain architecture and homology to other TPR-containing proteins[1][3][6].

Other names
Tetratricopeptide repeat protein 34TTC34TPR repeat protein 34TPR repeat-containing protein ENSP00000383873
02

Mechanism of action

null

03

Biological functions

Predicted role in protein–protein interactions as a scaffold, due to the TPR motif's known propertiesPossible involvement in cellular processes that require assembly of multiprotein complexes, similar to other TPR-containing proteins
04

Disease associations

Other

Beyond the preview

Go deeper on Tetratricopeptide repeat domain 34 (TTC34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetratricopeptide repeat domain 34 (TTC34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call